You just read:

New NCCN Breast Cancer Guidelines Elevate Oncotype DX Breast Recurrence Score® as the Only Preferred Multi-gene Test to Predict Chemotherapy Treatment

News provided by

Genomic Health, Inc.

09 Oct, 2018, 21:37 BST